Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03151642 · ClinicalTrials.gov registry record
A Pilot Study OF Diffusion Weighted MRI TO Assess Esophageal Tumor Resonse TO Neoadjuvant Chemoradiation
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 11
- Enrollment target
NCT03151642: Completed study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT03151642 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03151642 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The purpose of this research study will be to determine the sensitivity and specificity of dwMRI metrics to assess tumor response following neoadjuvant chemoradiation in esophageal cancer. This pilot study will generate the preliminary data needed for the design of a statistically-justified trial that would investigate dwMRI as an integral biomarker to stratify patients for escalated therapy to improve outcomes. We hope to develop dwMRI as a predictive clinical tool for a personalized treatment model that can identify patients who may be candidates for organ-preservation or treatment intensification to improve outcomes in esophageal cancer.
Interventions
- RADIATION Radiation Therapy
- PROCEDURE Surgery
- RADIATION Chemotherapy
- OTHER Blood Draws
- DEVICE MRI Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-04-05 |
| Est. Completion | 2021-04-23 |
What the finished NCT03151642 record still lists
NCT03151642 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which Radiation Therapy is the first listed.
NCT03151642 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03151642 about?
NCT03151642 is a clinical study titled "A Pilot Study OF Diffusion Weighted MRI TO Assess Esophageal Tumor Resonse TO Neoadjuvant Chemoradiation". The purpose of this research study will be to determine the sensitivity and specificity of dwMRI metrics to assess tumor response following neoadjuvant chemoradiation in esophageal cancer. This pilot study will generate the preliminary data needed for the design of a statistically-justified trial th...
What is the current status of trial NCT03151642?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2017-04-05. Estimated completion is 2021-04-23.
What interventions are being tested in trial NCT03151642?
The interventions under investigation include: Radiation Therapy (RADIATION), Surgery (PROCEDURE), Chemotherapy (RADIATION), Blood Draws (OTHER), MRI Imaging (DEVICE).
Who is sponsoring clinical trial NCT03151642?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI